Outpatient Administration of R-DHAP in Relapsed/Refractory Non-Hodgkin Lymphoma

NCT03892421 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Non Hodgkin Lymphoma
Refractory Non-Hodgkin Lymphoma

Interventions

DRUG: Rituximab
DRUG: Carboplatin
DRUG: Cytarabine Injection
DRUG: Dexamethasone
DRUG: Filgrastim 0.3 MG/ML

Sponsor

La Raza Medical Center